Read more about this article at The New York Times, MSNBC, or listen to a report on NPR (RealPlayer required).
Harvard/Public Citizen Study Finds Voluntary HMO
CAW, auto makers laud health system
By GREG KEENAN AUTO INDUSTRY REPORTER
THE GLOBE AND MAIL
Friday, September 13, 2002 – Print Edition, Page B5
Canada's system of government-financed health care represents about half
Single Payer Moves Ahead
Study consultant selected, Outreach Intensifies
There have been many significant steps towards Universal Single Payer Health Care in Maine during the past six months. We are now
Rex Morgan's prescription: socialized medicine in U.S.
JAMES ADAMS
NATIONAL ARTS CORRESPONDENT
Supporters of socialized health care in Canada and the United States have a seemingly unlikely friend in Rex Morgan M.D., the handsome,
Rex Morgan’s prescription: socialized medicine in U.S.
JAMES ADAMS
NATIONAL ARTS CORRESPONDENT
Supporters of socialized health care in Canada and the United States have a seemingly unlikely friend in Rex Morgan M.D., the handsome,
Dividing up health care by income class
By Uwe E. Reinhardt
FEDERAL BUDGETS can be viewed as memorand ums in which the president and the majority of the Congress tell God about the
Spring Meeting Agenda
In MS Word format.
The Rise of For Profit Medicine
By Uwe E. Reinhardt
FROM THE perspective of someone whose social ethic was forged first in Europe and then in Canada, the current brouhaha over ''boutique
Health Care for All – Oregon
Folk,Ê
A conservative call for universal access to health care
By Donald W. Light, Ph.D.Commonweal, February 22, 2002By Donald W. Light, Ph.D. | Commonweal
The United States remains the only industrialized or second-tier country in the
For-Profit Health Care: Expensive, Inefficient and Inequitable
Dr. Arnold S. Relman, Professor Emeritus of Medicine and Social Medicine at Harvard Medical School and Emeritus Editor-in-Chief of the New England Journal of Medicine,
Glaxo Attempts to Block Access To Generic AIDS Drugs in Ghana
Mark Schoofs
Staff Reporter, The Wall Street Journal
In the midst of the wrenching international debate over how to get expensive HIV drugs into Africa, pharmaceutical giant